| Intervention Area | Comparison Area | Effect | ||||||
---|---|---|---|---|---|---|---|---|---|
Intention to treat * | Events | PYAR | Rate | Events | PYAR | Rate | RR (95% CI) | p value | PE (95% CI) |
Health centre attendance (first or only) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
crude | 2160 | 1535.3 | 1.407 | 2067 | 1434.4 | 1.441 | 0.97 (0.92-1.04) | 0.417 | 3% (-4%,8%) |
adjusted ‡ |  |  |  |  |  |  | 1.04 (0.75-1.45) | 0.795 | -4% (-45%,25%) |
Health centre attendances (all episodes) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
crude | 3631 | 1810.5 | 2.005 | 3425 | 1699.3 | 2.015 | 0.99 (0.95-1.04) | 0.834 | 1% (-4%,5%) |
adjusted †‡ |  |  |  |  |  |  | 1.05 (0.75-1.48) | 0.736 | -5% (-48%,25%) |
 | IPTi Intervention Area | Corresponding EPI vaccine Comparison Area | Effect | ||||||
Per protocol ** | Events | PYAR | Rate | Events | PYAR | Rate | RR (95% CI) | p value | PE (95% CI) |
Health centre attendances (all episodes) in ATAR since IPTi dose | Â | Â | Â | Â | Â | Â | Â | Â | Â |
IPTi dose 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
crude | 1109 | 565.2 | 1.960 | 1082 | 466.6 | 2.317 | 0.84 (0.78-0.92) | 0.001 | 16% (8%,22%) |
adjusted †‡ |  |  |  |  |  |  | 0.98 (0.69-1.38) | 0.907 | 2% (-38%,31%) |
Health centre attendance (all episodes) within 28 days of IPTi dose | Â | Â | Â | Â | Â | Â | Â | Â | Â |
IPTi dose 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
crude | 106 | 93.7 | 1.131 | 125 | 80.3 | 1.556 | 0.73 (0.56-0.94) | 0.016 | 27% (6%,44%) |
adjusted †‡ |  |  |  |  |  |  | 0.82 (0.48-1.40) | 0.421 | 18% (-40%,52%) |